Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Arch Biochem Biophys ; 709: 108970, 2021 09 30.
Article in English | MEDLINE | ID: mdl-34181873

ABSTRACT

Glutaric acidemia type 1 (GA1) is caused by glutaryl-CoA dehydrogenase deficiency that leads to a blockage in the metabolic route of the amino acids lysine and tryptophan and subsequent accumulation of glutaric acid (GA), 3-hydroxyglutaric acids and glutarylcarnitine (C5DC). Patients predominantly manifest neurological symptoms, associated with acute striatal degeneration, as well as progressive cortical and striatum injury whose pathogenesis is not yet fully established. Current treatment includes protein/lysine restriction and l-carnitine supplementation of (L-car). The aim of this work was to evaluate behavior parameters and pro-inflammatory factors (cytokines IL-1ß, TNF-α and cathepsin-D levels), as well as the anti-inflammatory cytokine IL10 in striatum of knockout mice (Gcdh-/-) and wild type (WT) mice submitted to a normal or a high Lys diet. The potential protective effects of L-car treatment on these parameters were also evaluated. Gcdh-/- mice showed behavioral changes, including lower motor activity (decreased number of crossings) and exploratory activity (reduced number of rearings). Also, Gcdh-/- mice had significantly higher concentrations of glutarylcarnitine (C5DC) in blood and cathepsin-D (CATD), interleukin IL-1ß and tumor factor necrosis alpha (TNF-α) in striatum than WT mice. Noteworthy, L-car treatment prevented most behavioral alterations, normalized CATD levels and attenuated IL-1ß levels in striatum of Gcdh-/- mice. Finally, IL-1ß was positively correlated with CATD and C5DC levels and L-car was negatively correlated with CATD. Our results demonstrate behavioral changes and a pro-inflammatory status in striatum of the animal model of GA1 and, most importantly, L-car showed important protective effects on these alterations.


Subject(s)
Amino Acid Metabolism, Inborn Errors/drug therapy , Brain Diseases, Metabolic/drug therapy , Carnitine/therapeutic use , Glutaryl-CoA Dehydrogenase/deficiency , Inflammation/drug therapy , Neuroprotective Agents/therapeutic use , Amino Acid Metabolism, Inborn Errors/genetics , Animals , Brain Diseases, Metabolic/genetics , Carnitine/analogs & derivatives , Carnitine/metabolism , Cathepsin D/metabolism , Corpus Striatum/drug effects , Corpus Striatum/metabolism , Glutaryl-CoA Dehydrogenase/genetics , Grooming/drug effects , Inflammation/genetics , Interleukin-1beta/metabolism , Locomotion/drug effects , Lysine/pharmacology , Mice, Knockout , Open Field Test/drug effects , Transforming Growth Factor beta/metabolism
2.
Metab Brain Dis ; 30(5): 1167-74, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26002427

ABSTRACT

Maple Syrup Urine Disease (MSUD) is a metabolic disorder caused by a severe deficiency of the branched-chain α-keto acid dehydrogenase complex activity which leads to the accumulation of branched-chain amino acids (BCAA) leucine (Leu), isoleucine and valine and their respective α-keto-acids in body fluids. The main symptomatology presented by MSUD patients includes ketoacidosis, failure to thrive, poor feeding, apnea, ataxia, seizures, coma, psychomotor delay and mental retardation, but, the neurological pathophysiologic mechanisms are poorly understood. The treatment consists of a low protein diet and a semi-synthetic formula restricted in BCAA and supplemented with essential amino acids. It was verified that MSUD patients present L-carnitine (L-car) deficiency and this compound has demonstrated an antioxidant and anti-inflammatory role in metabolic diseases. Since there are no studies in the literature reporting the inflammatory profile of MSUD patients and the L-car role on the inflammatory response in this disorder, the present study evaluates the effect of L-car supplementation on plasma inflammatory cytokines interleukin-1ß (IL-1ß), interleukin-6 (IL-6), interferon-gamma (INF-É£), and a correlation with malondialdehyde (MDA), as a marker of oxidative damage, and with free L-car plasma levels in treated MSUD patients. Significant increases of IL-1ß, IL-6, and INF-É£ were observed before the treatment with L-car. Moreover, there is a negative correlation between all cytokines tested and L-car concentrations and a positive correlation among the MDA content and IL-1ß and IL-6 values. Our data show that L-car supplementation can improve cellular defense against inflammation and oxidative stress in MSUD patients and may represent an additional therapeutic approach to the patients affected by this disease.


Subject(s)
Carnitine/therapeutic use , Dietary Supplements , Inflammation Mediators/blood , Maple Syrup Urine Disease/blood , Maple Syrup Urine Disease/drug therapy , Child , Child, Preschool , Female , Humans , Inflammation/blood , Inflammation/drug therapy , Male
3.
Cell Mol Neurobiol ; 35(6): 899-911, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25805165

ABSTRACT

Cystathionine-ß-synthase (CBS) deficiency is the main cause of homocystinuria. Homocysteine (Hcy), methionine, and other metabolites of Hcy accumulate in the body of affected patients. Despite the fact that thromboembolism represents the major cause of morbidity in CBS-deficient patients, the mechanisms of cardiovascular alterations found in homocystinuria remain unclear. In this work, we evaluated the lipid and inflammatory profile, oxidative protein damage, and the activities of the enzymes paraoxonase (PON1) and butyrylcholinesterase (BuChE) in plasma of CBS-deficient patients at diagnosis and during the treatment (protein-restricted diet supplemented with pyridoxine, folic acid, betaine, and vitamin B12). We also investigated the effect of folic acid and vitamin B12 on these parameters. We found a significant decrease in HDL cholesterol and apolipoprotein A1 (ApoA-1) levels, as well as in PON1 activity in both untreated and treated CBS-deficient patients when compared to controls. BuChE activity and IL-6 levels were significantly increased in not treated patients. Furthermore, significant positive correlations between PON1 activity and sulphydryl groups and between IL-6 levels and carbonyl content were verified. Moreover, vitamin B12 was positively correlated with PON1 and ApoA-1 levels, while folic acid was inversely correlated with total Hcy concentration, demonstrating the importance of this treatment. Our results also demonstrated that CBS-deficient patients presented important alterations in biochemical parameters, possibly caused by the metabolites of Hcy, as well as by oxidative stress, and that the adequate adherence to the treatment is essential to revert or prevent these alterations.


Subject(s)
Aryldialkylphosphatase/blood , Butyrylcholinesterase/blood , Homocystinuria/blood , Lipids/blood , Oxidants/blood , Adolescent , Adult , Case-Control Studies , Child , Child, Preschool , Cystathionine beta-Synthase/deficiency , Cystathionine beta-Synthase/genetics , Female , Folic Acid/blood , Folic Acid/physiology , Homocystinuria/genetics , Humans , Male , Oxidative Stress/physiology , Vitamin B 12/blood , Vitamin B 12/physiology , Young Adult
4.
Brain Res Bull ; 92: 60-8, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23270878

ABSTRACT

Epilepsy, which is one of the most common neurological disorders, involves the occurrence of spontaneous and recurrent seizures that alter the performance of the brain and affect several sensory and behavioral functions. Oxidative damage has been associated with post-seizure neuronal injury, thereby increasing an individual's susceptibility to the occurrence of neurodegenerative disorders. The present study investigated the possible anticonvulsive and neuroprotective effects of organic and conventional yerba mate (Ilex paraguariensis), a plant rich in polyphenols, on pentylenetetrazol (PTZ)-induced seizures in Wistar rats. The behavioral and polyphenolic profiles of the yerba mate samples were also evaluated. Infusions of yerba mate (50mg/kg) or distilled water were given to rats for fifteen days by oral gavage. On the 15th day the animals were subjected to open field test, and exploratory behavior was assessed. Subsequently, 60mg/kg PTZ (i.p.) was administered, and animals were observed for the appearance of convulsions for 30min. Latency for the first seizure, tonic-clonic and generalized seizures time, frequency of seizures and mortality induced by PTZ were recorded. The animals were then sacrificed, and the cerebellum, cerebral cortex and hippocampus were quickly removed and frozen to study the neuroprotective effects of yerba mate. The oxidative damage in lipids and proteins, nitric oxide levels, the activities of the antioxidant enzymes superoxide dismutase (Sod) and catalase (Cat) and non-enzymatic cellular defense (sulfhydryl protein) were quantified in all the tissues. The results showed that organic and conventional yerba mate infusions were able to reduce the frequency of seizures when compared to the PTZ group. Besides, organic yerba mate infusion decreases the tonic-clonic seizures time in relation to the PTZ group. It was also shown that organic and conventional yerba mate infusions reduced the oxidative damage in lipids and proteins and nitric oxide levels and prevented the decrease in Sod and Cat activities and sulfhydryl protein content when compared to the PTZ group in all the CNS tissues assayed. Organic and conventional yerba mate commercial samples did not change the behavior (locomotion, exploration or anxiety) of the treated animals. In both organic and conventional infusions, the presence of the polyphenols rutin, chlorogenic acid and their acyl derivatives were detected, which could be associated with the biological effects observed. These data indicate that yerba mate may provide new perspectives for the development of therapeutic approaches with natural compounds in the pharmaceutical area, both to reduce the convulsions' frequency and to minimize the neuronal damage associated with recurrent seizures.


Subject(s)
Anticonvulsants/therapeutic use , Ilex paraguariensis , Phytotherapy/methods , Plant Extracts/therapeutic use , Seizures/drug therapy , Seizures/physiopathology , Analysis of Variance , Animals , Anticonvulsants/chemistry , Catalase/metabolism , Chromatography, High Pressure Liquid , Convulsants/toxicity , Disease Models, Animal , Male , Maze Learning/drug effects , Nitric Oxide/metabolism , Pentylenetetrazole/toxicity , Plant Extracts/chemistry , Protein Carbonylation/drug effects , Rats , Rats, Wistar , Seizures/chemically induced , Superoxide Dismutase/metabolism , Thiobarbituric Acid Reactive Substances/metabolism
5.
Neurochem Int ; 60(8): 799-805, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22465942

ABSTRACT

Epilepsy is the most common neurological disorder worldwide. Studies have shown that recurrent seizures may increase the concentration of reactive oxygen species, which can lead to oxidative stress and neuronal damage. These seizures result in substantial deleterious effects on an individual's health. Organic and conventional grape juices are rich in polyphenols, compounds with important antioxidant activity. However, these juices could have differences in their polyphenol content. The aim of this study was to investigate the neuroprotective and anticonvulsant effects of organic and conventional grape juice treatments in Wistar rats against pentylenetetrazole (a convulsant drug)-induced damage. In addition, we evaluated potential behavioral changes in rats treated with the juices and the polyphenolic profile of those samples. Animals (n=16 in each group) received treatment with saline, organic or conventional grape juice for 17 days. On the eighteenth day, behavioral changes were evaluated by an open field test. Afterwards, half of the rats from each group received pentylenetetrazole and were observed for 30 min to evaluate possible seizure characteristics. The animals were subsequently killed by decapitation and their hippocampus, cerebellum and cerebral cortex tissues were isolated. The results of this study showed that neither organic nor conventional grape juice altered the behavior parameters, and no statistical differences were observed in the seizure characteristics of the groups. Nevertheless, both juice types were able to protect from lipid and protein oxidative damage, decrease nitric oxide content and increase enzymatic (superoxide dismutase and catalase) and non-enzymatic (sulfhydryl protein) antioxidant defenses in brain tissues following pentylenetetrazole-induced seizures. In general, organic juice showed superior results in each test, probably due to its higher polyphenol content relative to conventional juice. These results indicate that grape juices can provide further insight into natural neuroprotective compounds and may lead to the development of new therapeutic strategies for epileptic patients.


Subject(s)
Pentylenetetrazole/toxicity , Plant Extracts/therapeutic use , Seizures/drug therapy , Vitis/chemistry , Animals , Male , Rats , Rats, Wistar , Seizures/chemically induced
6.
Rev. AMRIGS ; 52(3): 182-186, jul.-set. 2008. graf, tab
Article in Portuguese | LILACS | ID: biblio-849408

ABSTRACT

Introdução: O objetivo do presente estudo foi analisar a eficácia da utilização da Cordia salicifolia em camundongos submetidos a dieta hiperlipidêmica, através do monitoramento dos índices sorológicos de colesterol e triglicerídeos. Metodologia: Para o experimento foram usados camundongos (mus musculus), com peso médio de 54 ± 5 g, e com idade de 50 ± 5 dias, que foram divididos em 4 grupos de 10 animais. Camundongos recebendo água e com dieta normal, camundongos recebendo água e com dieta hiperlipidêmica, camundongos com dieta normal e administração do extrato de Cordia salicifolia e camundongos com dieta hiperlipidêmica e administração do extrato de Cordia salicifolia. Resultados e conclusões: Houve redução nos níveis séricos de colesterol total, tanto no grupo que recebeu dieta normal + extrato como no grupo com dieta hiperlipidêmica + extrato. Também foi significativa a redução nos níveis séricos de triglicerídeos nos animais que receberam dieta hiperlipidêmica + extrato, quando comparados aos camundongos que receberam dieta hiperlipidêmica + água (AU)


Introduction: The present study evaluates the effectiveness of Cordia salicifolia in reducing serum total cholesterol and triglyceride levels in mice on a hyperlipidemic diet. Methodology: 40 specimens of mice (Mus musculus, mean weight 54 ±5 g and mean age 50 ± 5 days) were studied. They were divided into 4 groups of 10 animals each: mice on a normal diet receiving water, mice on a hyperlipidemic diet receiving water, mice on a normal diet receiving Cordia salicifolia extract, and mice on a hyperlipidemic diet receiving Cordia salicifolia extract. Results and conclusion: There was a serum total cholesterol reduction in the normal diet + extract group as well as in the hyperlipidemic diet + extract group. Also, the serum triglyceride reduction observed in animals on the hyperlipidemic diet + extract was significant as compared to mice on the hyperlipidemic diet + water (AU)


Subject(s)
Animals , Male , Mice , Hypertriglyceridemia/prevention & control , Cordia/chemistry , Hypercholesterolemia/prevention & control , Plant Extracts/pharmacology , Phytotherapy
SELECTION OF CITATIONS
SEARCH DETAIL